Live and recent posts from across the Fediverse tagged #tumorboardtuesday, aggregated by home.social.
A very complex, but thought-provoking & necessary #TumorBoardTuesday
What happens when you have a patient on biologic therapy for an autoimmune disease/#IBD & they need #BreastCancer treatment?
Weigh in!
36yo 👩🏻🦱 self palpates a R breast mass.
PMH: Crohn’s disease - dx 34yo, perianal fistula w/abscess, achieving remission with infliximab/AZA.
🧪Workup: T2N1 TNBC germline neg
🤨What option would you consider?
@MPishvaian @JohnEbbenMDPhD
@breastcancernow @breastcancer @tumorboard
🌻We’re preparing #TumorBoardTuesday!
🧑🔬Join Dr Maryam Lustberg & Dr Adriana Kahn 08.01.23 8pm ET, for a walk through TNBC tx while pt on IS for #Crohns
🌻Don’t miss this essential MDT chat!
🧠Grab FREE #CME credits
👉🏽Visit integrityce.com/TBT2023 for more info
@JohnEbbenMDPhD @MPishvaian #OncoDon #PrecisionMedicine #Oncology #IBD #PrecisionOncology #BreastCancer #Cancer
🔥 #TumorBoardTuesday is a must-attend!
🧑🔬Join @marklewismd @CatherineaOC 07.25.23 8pm ET as they explore differentiating midgut & #PNETs
🔥Be part of an insightful discussion!
🧠Get FREE #CME credits as we finalize the case
👉🏽Visit integrityce.com/TBT2023 for more info #OncoDon #GastroDon
#PrecisionMedicine #Oncology #Pancreas #NETs
#NeuroendocrineTumor @MPishvaian @JohnEbbenMDPhD @EmpoweringPts9 @tumorboard @tumor
It's ALMOST time for the #TumorBoardTuesday case wrap up. We apologize for the delay, but promise it will be worth it!
Check back Saturday for our exclusive interview w @RachelRiechelm2 as we talk implications of hypermutation in #NET- don't miss it! https://twitter.com/i/web/status/1654634595868987394
Thank you to @jessrzanotti & @RachelRiechelm2 for an exceptional #TumorBoardTuesday on hypermutation in #NET- how might this change care in the future?
Check out thread below & answer the question at the end to get free #CME!
Special edition of Case Wrap Up drops tomorrow!💡
---
RT @jessrzanotti
@TumorBoardTues @RachelRiechelm2 @MPishvaian @JohnEbbenMDPhD @PamelaKunzMD @marklewismd @DianeReidyLagun @timpawlik @CanHealeu @duiliorocha_…
https://twitter.com/jessrzanotti/status/1653555761094557697
📢 Join our 🇧🇷 Brazilian-led #TumorBoardTuesday!!
🥼@RachelRiechelm2 @jessrzanotti teach us treating hypermutation induced in NET #PancreaticCancer
👇🏽
📱Weigh in
🧾Bring receipts
🙋Ask Q’s
📊check polls
🔁RT
👩🏻⚕️tag peers
@MPishvaian @JohnEbbenMDPhD
#MedTwitter #WomenInOncology
---
RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass …
https://twitter.com/jessrzanotti/status/1653549758072471553
🦓1 hour until TONIGHT'S #TumorBoardTuesday!!
🇧🇷@RachelRiechelm2 @jessrzanotti take us through treatment of hypermutation induced by alkylating agent in #PanCan
🦓Finish dinner, grab a drink, and prepare your 🧠 with these #CME
👇🏽See you soon!
---
RT @TumorBoardTues
#TumorBoardTuesday #PreTest Q1⃣
Free #CME🔗http://integrityce.com/TBT2023
📣B4 @RachelRiechelm2 @jessrzanotti teach us hypermutation #NETCancer test your🧠
🤔Which 2L fo…
https://twitter.com/TumorBoardTues/status/1653449001700556816
🇧🇷 Be sure to join #TumorBoardTuesday 05/02 at 8pm! #PanCan #NETCancer
@PreetpaulS @JaydiDelRivero @TClancyMD @LMFendo @ShaalanBeg @HealingNET1 @laylaPLANETSCh1 @DrMohidKhan @ShalabyK @jgong15 @drjasonstarr @NVijayvergiaMD @jhatjhmi1 @GillSharlene @nanudasmd @DrSukeshiArora… https://twitter.com/i/web/status/1653106342792396800
And to help us guide the discussion tell us your connection to🩺cases like these👇
#TumorBoardTuesday
😀I am particularly excited to hear about this #PNET case presented by @RachelRiechelm2 & @jessrzanotti
Join us📆Tuesday, May 2nd at🕖8PM ET/9PM BRT for a spirited discussion
Set a ⏲ to join a 🇧🇷Brazilian-led #TumorBoardTuesday on 05.02.23!
📅8pm ET/9pm BRT
👩🏻⚕️ @RachelRiechelm2 @jessrzanotti 👩🏻⚕️
📰 Hypermutation induced by alkylating agent in a pancreatic neuroendocrine tumor #NETCancer #PancreaticCancer
Remember #TumorBoardTuesday continues to offer CME credit for FREE! Don’t forget to answer the polls👇🏽
Then click this link to quickly request your credit!
CME eval🔗: http://integrityce.com/TBTeval23
ALL CME 🔗: http://integrityce.com/TBT2023
---
RT @JennyCarlisleMD
@TumorBoardTues @LealTiciana @FordePatrick @DrMarkAwad @JulieBrahmer @TonyMok9 @RamalingamMD @RachelSanbornMD @KarenReckampMD @AnaVManana @DevikaDasMD @JSabari @Exon20…
https://twitter.com/JennyCarlisleMD/status/1651029559205154817
8/8 #TumorBoardTuesday
Thursday Case🎀
🙏Precision approaches continue to offer better options for EGFR ex20 #NSCLC
➡️Join us on May 2, 2023 when @RachelRiechelm2 @jessrzanotti present a unique panc neuroendocrine tumor complicated by hypermutation related to tx!
7/8 #TumorBoardTuesday
Thurs Case🎀
On the horizon: 1L ex20 directed tx
🦋PAPILLON= ami: https://clinicaltrials.gov/ct2/show/NCT04538664
‼️ EXCLAIM-2=mobo:
https://clinicaltrials.gov/ct2/show/NCT04129502
Both use plat backbone. NEED better solutions to plat chemo shortage that could limit ability to provide the best care!
6/8 #TumorBoardTuesday
Thurs Case🎀
📷 TBT in an image
How to choose btwn ex20 🎯? Focus on pt!
🔹Route of admin- strong pref for PO vs IV? Consider 💸copays!
🔹SE prof- ex if pt w sig GI issues, may want to try ami 1st.
🔹Ami &mobo=diff MOA- can try alt agent on progression
5/8 #TumorBoardTuesday
Thurs Case🎀
🎥 TBT in a video: Part 3-
✅Mobocertinib= next gen EGFR TKI effective against ex20ins.
✅ORAL admin, but 👀for high rates of severe diarrhea 💩. Early anti-diarrheals, dose holds 🗝️
✅New agents coming w better CNS penetration!
Remember #TumorBoardTuesday continues to offer CME credit for FREE! Don’t forget to answer the polls👇🏽
Then click this link to quickly request your credit!
CME eval🔗: http://integrityce.com/TBTeval23
ALL CME 🔗: http://integrityce.com/TBT2023
---
RT @JennyCarlisleMD
@TumorBoardTues @LealTiciana @FordePatrick @DrMarkAwad @JulieBrahmer @TonyMok9 @RamalingamMD @RachelSanbornMD @KarenReckampMD @AnaVManana @DevikaDasMD @JSabari @Exon20…
https://twitter.com/JennyCarlisleMD/status/1651029559205154817
7/8 #TumorBoardTuesday
Thurs Case🎀
On the horizon: 1L ex20 directed tx
🦋PAPILLON= ami: https://clinicaltrials.gov/ct2/show/NCT04538664
‼️ EXCLAIM-2=mobo:
https://clinicaltrials.gov/ct2/show/NCT04129502
Both use plat backbone. NEED better solutions to plat chemo shortage that could limit ability to provide the best care!
2/8 #TumorBoardTuesday
Thurs Case🎀
✅Next gen seq=ESSENTIAL. PCR misses EGFR exon20 ins!
✅CHRYSALIS: Amivantamab (EGFR/MET Bispecifc mAb) 2L
✅EXCLAIM: Mobocertinib (EGFR TKI) 2L
✅1L= Plat chemo; 2L= ami/mobo
📚 @LealTiciana @JennyCarlisleMD’s thread
https://threadreaderapp.com/thread/1651013513530204161.html
📢 #TumorBoardTuesday is here!!
🥼@LealTiciana @JennyCarlisleMD teach us about treating exon 20 insertion in #NSCLC
👇🏽👇🏽
📱Weigh in your answers
🧾Bring receipts
🙋Ask Q’s
📊check the polls
🔁RT
👩🏻⚕️tag peers👩🏻⚕️
@MPishvaian @JohnEbbenMDPhD
#MedTwitter #LungCancer
---
RT @JennyCarlisleMD
@TumorBoardTues @LealTiciana 1/21 #TumorBoardTuesday #LungCancer #OncTwitter
47yo 👨🏽💼🚭
No significant PMHx
Incidental 📏 2.8cm cavitary RLL nodule …
https://twitter.com/JennyCarlisleMD/status/1651013513530204161
🫁under 1 hour until TONIGHT'S #TumorBoardTuesday!!
🫁 @LealTiciana @JennyCarlisleMD takes us through treating exon 20 insertion in #NSCLC
🫁 Grab a snack, get the last minute chair dances, and prepare your 🧠 with these #CME👇🏽
See you soon!
---
RT @TumorBoardTues
#TumorBoardTuesday
#PreTest Q1⃣
Free #CME 🔗 http://integrityce.com/TBT2023
@LealTiciana & @JennyCarlisleMD
🤔How would you Tx your 47yo♂️patient who developed multiple …
https://twitter.com/TumorBoardTues/status/1650901866161782784
🫁Tuesday 04.25.23 at 8pm ET @LealTiciana @JennyCarlisleMD take us through Exon 20ins Treatment in #NSCLC!
💬Join us here on #TumorBoardTuesday!
🧠While we finalize the case details, collect FREE #CME
👉🏽http://integrityce.com/TBT2023👈🏼 #OncTwitter #LCSM @MPishvaian @JohnEbbenMDPhD
Thank you to the #MedTwitter #OncTwitter community - We couldn't have successful #TumorBoardTuesday without your support, encouragement, and engagement!
#LCSM #BCSM #GITwitter #PanCan #GU #HemOnc
🎉While we were on hiatus, we received notification of our #ASCO23 abstract acceptance for discussion!!
We’re thrilled to bring more awareness of the impact #TumorBoardTuesday discussions continue to have on knowledge of novel therapies and toxicities in solid tumor oncology!🙏🏼
#TumorBoardTuesday
🔬🧬A discussion on adjuvant tx options, biomarkers, & fertility preservation in #BreastCancer led by @JenniferLitton @marijasullivan
➡️Here’s the Thurs Case🎀
🆓 #CME credit: answer 2 ❓
ALL CME 🔗: http://integrityce.com/TBT2023
CME eval🔗: http://integrityce.com/TBTeval23
We've noticed quite a bit of technical issues on our #TumorBoardTuesday feed today.
Have no fear, @marijasullivan @JenniferLitton awesome tweetorial is posted, & we'll continue this particular BRCA+ #BreastCancer convo debate until @JohnEbbenMDPhD begins the wrap up! @MPishvaian
📌Don’t forget as always, edu of #TumorBoardTuesday is beyond Twitter - we offer 🆓 CME!!
Pick your #CME by answering 2 quick q’s on a case similar to @JenniferLitton @marijasullivan’s
CME eval http://integrityce.com/TBTeval23
ALL CME http://integrityce.com/TBT2023
🎁
---
RT @marijasullivan
@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melind…
https://twitter.com/marijasullivan/status/1648493112837414913
Thank you 🙏🏼for an up to date & instructive #TumorBoardTuesday!!
Look for Case Wrap Up 🎀 Thursday 04/20/23
📅 Please join us Tuesday at 8pm ET for @LealTiciana @JennyCarlisleMD to join us to chat Exon 20ins TX in #NSCLC
📢 FINALLY #TumorBoardTuesday is here!!
🥼@JenniferLitton @marijasullivan teach us treating early stage BRCA+ #BreastCancer in the younger patient
👇🏽👇🏽
📱Weigh in your answers
🧾Bring receipts
🙋Ask Q’s
📊check polls
🔁RT
👩🏻⚕️tag peers👩🏼⚕️
@MPishvaian @JohnEbbenMDPhD
#MedTwitter
---
RT @marijasullivan
@TumorBoardTues @JenniferLitton 1/18 #TumorBoardTuesday #BreastCancer #OncTwitter
32 yo 👩🏽
4 months post-partum
🚫comorbidities
FHx pat…
https://twitter.com/marijasullivan/status/1648476524369313797
🌻The above & upcoming #TumorBoardTuesday discussion with moderators @JenniferLitton @marijasullivan is provided by @IntegrityCE
🌼Supported by edu grants from @AstraZeneca @GileadSciences Merck Sharp & Dohme Corp, SeaGen
🌻More info about our free CME: http://integrityce.com/TBT2023
💃🏻The above & upcoming #TumorBoardTuesday discussion with moderators @drsarahsam @PTarantinoMD is provided by @IntegrityCE
🕺🏻Supported by educational grants from @AstraZeneca @DaiichiSankyoUS Merck Sharp & Dohme Corp
More info about our free CME & MOC: http://integrityce.com/tbt
#TumorBoardTuesday
👉🏽#CME🔗 http://integrityce.com/tbt
😀We are looking forward to the🗣️on CDK4/6 inhibitors led by @PTarantinoMD & @drsarahsam Tuesday 02.28.23 at 8pm ET
🙋♂️BUT b4⃣ the🗣️, we want to know who you are‼️
👉🏽Please tell us where you are in your🩺journey🛣️
👇🏽👇🏽👇🏽
💎Tuesday 02.28.23 at 8pm ET @drsarahsam @PTarantinoMD takes us through CDK 4/6 inhibitors for #BreastCancer
💬Join us here on #TumorBoardTuesday!
🧠While we finalize the case details, collect FREE #CME (AMA & MOC)
#TumorBoardTuesday
👉🏽#CME🔗 http://integrityce.com/tbt
😀We are so glad to have you join into the discussion🗣️with @NarjustFlorezMD and @ShrutiPatelMD on IO combos for #NSCLC 🙏
🙋♂️BUT - we want to know who you are‼️
👉🏽So, please tell us where you are in your🩺journey🛣️
👇🏽👇🏽👇🏽
Set a ⏲ to join #TumorBoardTuesday on 02.21.23 at 8pm ET
👩🏻⚕️@NarjustFlorezMD @ShrutiPatelMD👩🏽⚕️
📰Options for IO combos for treatement of #NSCLC
🫁While we finalize the case, collect FREE #CME (AMA & MOC)
👉🏽http://integrityce.com/tbt 👈🏼#OncTwitter #LungCancer #LCSM
🚨AWESOME networking op for #oncology fellows!🚨
@TumorBoardTues is 👀for fellows interested in precision onc & immunotx to pair up w faculty around the 🌎 to co-lead cases.
Tell us what you're interested in, and we'll find a mentor for you to present with! #MedTwitter
---
RT @TumorBoardTues
#TumorBoardTuesday
📢CALLING ALL FELLOWS📢
➡️Would you like to co-lead a @TumorBoardTues case discussion in 2023❓❓❓
👉Fill out this BRIEF survey📃…
https://twitter.com/TumorBoardTues/status/1626346939267571714
3/#TumorBoardTuesday #gyncsm #OncTwitter
🤔Missed the #EndometrialCancer #MedTweetorial earlier this wk?
🤯Feeling left behind?
Don't fret, it's here📍
---
RT @BonumCe
1/ #OncTwitter #TumorBoardTuesday
✅#EndometrialCancer #MedTweetorial🧵
w @DrMMurphy @MeganLeigh127 @TumorBoardTues
🧬Tx response
🧪Trial results
🔬Tox for TKI-ICI
🆓#CME 🔗 http://bit.ly/3VBGJEJ
Supported by educational grants from Eisai & @Merck
https://twitter.com/BonumCe/status/1615519240542646275
💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 http://bit.ly/3Vqtabi 👈 @BonumCe ┈┈┈🔸Supported by edu grants from Eisai & @Merck 🔹#TumorBoardTuesday #gyncsm #OncTwitter https://twitter.com/i/broadcasts/1yoJMZrrqbNxQ
5...4...3...2...1...it's the final countdown
⏰30m warning
🔥#EndometrialCancer #webinar w @DrMMurphy & @drteplinsky🔥
👩🏫B4 we begin...👩🏻🏫
✅Answer #PreTest polls 👇
🔁Retweet & tag colleagues
#TumorBoardTuesday #OncTwitter #MedTwitter #GynCSM #gynonc
---
RT @TumorBoardTues
2/#TumorBoardTuesday #OncTwitter #GynCSM #gynonc
#CME🔗http://bit.ly/3YRDkog
🟢#PreTest Q 1️⃣
📊Diarrhea, nausea, & vomiting are common GI toxicities associated w…
https://twitter.com/TumorBoardTues/status/1616204008028528643
#TumorBoardTuesday #PreTest Q2️⃣ @PGrivasMDPhD @rafee_talukder @MPishvaian @JohnEbbenMDPhD #UrothelialCancer
👉🏽Free #CME🔗: http://integrityce.com/tbt
👉🏽CME Eval 🔗http://integrityce.com/tbtEval
How would you manage a Pt who presents with dry eyes and blurred vision while on erdafitinib❓
#TumorBoardTuesday #PreTest Q1️⃣
Free #CME🔗:http://integrityce.com/tbt
🤔B4⃣ @PGrivasMDPhD @rafee_talukder🗣️FGFR3 as a🎯in met Bladder Ca, test your🧠with these 2❓s:
Which💊would you choose for a 74yo♂️ with G2 neuropathy & FGFR3 mut➕met bladder Ca s/p Gem-cis⏩maint avelumab❓
❄️The above & upcoming #TumorBoardTuesday discussion with moderator @PGrivasMDPhD @rafee_talukder is provided by @IntegrityCE
❄️Supported by educational grants from @AstraZeneca, Exelixis, & Merck Sharp & Dohme Corp
❄️More info about our free CME & MOC: http://integrityce.com/tbt
👉🏽#CME🔗 http://integrityce.com/tbt
📊1 way #TumorBoardTuesday gathers input is with polls, so be sure to tick your box!
👨🏻⚕️Before @PGrivasMDPhD @rafee_talukder take us through treatment options for mutated advanced #UrothelialCancer
🧐Tell us where you are in your 🩺journey
👇🏽👇🏽
#TumorBoardTuesday
@PGrivasMDPhD & @rafee_talukder
📅Tuesday 01/10/23 at🕗8PM ET
✅polls
⚖️Weigh in
🧾Bring citations
🔁Retweet
🏷️tag your🩺colleagues
🏆Earn your🆓CME (AMA & MOC) http://integrityce.com/tbt
B4⃣ the case:
🧐Tell us where you are in your🩺journey
👇🏽👇🏽👇🏽
#TumorBoardTuesday #UrothelialCancer
OK all, the holidays are over & it's time to dive back into the🧑🎓. We are starting 2023💪with a close🔬at🎯FGFR3 in met bladder Ca
📢Join us Tuesday 01/10/23 at 8pm ET when @PGrivasMDPhD & @rafee_talukder lead the🗣️
✅Prepare your Q’s NOW
We’re kicking off year 3 of #TumorBoardTuesday with an 💥EPIC💥 #UroOncology duo from @UWMedicine!!
👨🏻⚕️@PGrivasMDPhD @rafee_talukder
📅Tuesday 01/10/23 at 8PM ET
📊polls
⚖️in & bring citations🧾
🔁Retweet & tag colleagues
🏆Earn your 🆓 CME & MOC
http://integrityce.com/tbt
Please join us for the first #TumorBoardTuesday of 2023!!
@tompowles1 @PBarataMD @FedGhali @TomJayram @arnabguonc @sonpavde @nataliagandur @LauraEsfeller @dawood_findakly @mtsiatas @RCCadvocate @AmandaNizamMD @QingZhangLab @PavlosMsaouel @OAlhalabiMD @uwradonc @UWMedicine
We’re baaaack!!
📆Tuesday 01.10.23 at 8pm ET @PGrivasMDPhD @rafee_talukder take us through treatment options for met #UrothelialCancer
💬Join us here on #TumorBoardTuesday!
🧠While we finalize case details, collect FREE #CME (AMA & MOC)
🎄**PLEASE REMEMBER** 🕎
🔒If you have a private Twitter account, we can’t see your responses during the discussion!! Please make your account public to allow interaction with the #TumorBoardTuesday community!!
📨If you need help with this, please message us privately! 🙏🏼
🔓
#TumorBoardTuesday #PreTest Q1️⃣
Free #CME🔗: http://integrityce.com/tbt
🤔B4⃣ @jane_meisel @quirogad🗣️2L #BRCA tx, test your🧠with these 2❓s:
What 2L tx would you pick for PD-L1-neg, HR-, HER2- (IHC 0) mBC who received 1L carbo/gem & BRCA+ after recurrence cycle 6 of lip doxo?
🌰The above & upcoming #TumorBoardTuesday discussion with moderator @jane_meisel @quirogad is provided by @IntegrityCE
🍑Supported by educational grants from @AstraZeneca @DaiichiSankyoUS Merck Sharp & Dohme Corp
🌰More info about our free CME & MOC: http://integrityce.com/tbt
#TumorBoardTuesday #breastcancer
@jane_meisel @quirogad
📅Tuesday, 12.20.22 at🕗8PM ET
✅polls
⚖️Weigh in
🧾Bring citations
🔁Retweet
🏷️tag your🩺colleagues
🏆Earn your🆓CME (AMA & MOC) http://integrityce.com/tbt
Before the case:🧐Tell us where you are in your 🩺 journey👇👇👇
🎉@TumorBoardTues has reached the end of our 2nd full year🥳. And to end with a💥 @jane_meisel & @quirogad will🗣️2L Tx for Pts with in #BRCA mutated #breastcancer
📢Join #TumorBoardTuesday 12.20.22 at 8pm ET
✅Prepare your own Q’s NOW
#TumorBoardTuesday #BreastCancer
👉🏽#CME🔗 http://integrityce.com/tbt
🩺Before @jane_meisel @quirogad take us through treating 2L BRCA mutation
🧐tell us where you are in your 🩺 journey
👇🏽👇🏽
@MPishvaian @JohnEbbenMDPhD @NicoleKuderer @Dr_Ivanoncologo @aLwOmbaT @LuisBlancoJrMD
#SABCS22 came & went, but the exciting info for #BreastCancer is continuing to come your way via #TumorBoardTuesday!!
@jane_meisel @quirogad
📅Tues, 12/20/22 at🕗8PM ET
✅polls
⚖️in & bring citations🧾
🔁Retweet & tag 🩺colleagues
🏆Earn your🆓CME & MOC http://integrityce.com/tbt
Set an alarm to join #TumorBoardTuesday👆🏼
@ukbreasthealth @uk_oncologist @cgonzagaj @MichaelMackley @DraAnaCasas @meganlcook @TheOtherDrX @PenaultLlorca @GeneticsRach @TheSarcasticOwl @GCSlaya @drkpavithran @caseofdees @jrgralow @lyndaweatherby @pozoparilli @stales @drznahleh
Please join #TumorBoardTuesday this Tuesday👆🏼
@z_veitch @4RiseUp @dradityabardia @DrHBurstein @DRNAVNEET83 @HHampel1 @sadia_ajaz @EmilyFassi @MilitaZaheed @emmaasnyder19 @puxip @gbc02 @marleahdeank @Ian_Portsmouth @obogler @G_Villacampa @minouye271 @cathrynlewis @LGerratana
💥Ending 2022 with a bang!💥
Set a ⏲ to join this #WomenInOncology duo for #TumorBoardTuesday on 12.20.22 at 8pm ET
👩🏻⚕️@jane_meisel @quirogad
📰2L Treatment in #BRCA mutation
While we finalize the case, collect FREE #CME (AMA & MOC)
❄️ 1 hour until TONIGHT'S #TumorBoardTuesday!!
❄️ @shilpaonc takes us through treating clear cell #RenalCellCarcinoma
❄️ Snag some hot chocolate (+Bailey’s 😉), grab a blanket, and prepare your 🧠 with these #CME👇🏽See you soon!
---
RT @TumorBoardTues
#TumorBoardTuesday #PreTest❓Free #CME🔗: http://integrityce.com/tbt
🤔B4⃣ @shilpaonc🗣️management of #RenalCell🦀, test your🧠with these 2❓s:
Q1⃣: What Tx would you choose for a PS=2 hom…
https://twitter.com/TumorBoardTues/status/1602811547075624961
15/ #TumorBoardTuesday #BonumCE #RenalCell
#OncTwitter #NephTwitter #MedTwitter
🟢Pt w mRCC
🔸Initiated tx w pembro + lenva
🔹Developed G3 diarrhea
🔸Lenva withheld & anti-diarrheal treatment initiated 🔹Diarrhea now resolved.
🟢What next step is best for the pt?